Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III renzapride trial in women with constipation-predominant irritable bowel syndrome
ISRCTN75871030Phase 3Completed
- Sponsor
- Alizyme
- Start
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of renzapride in irritable bowel syndrome (IBS) (3 arms), sponsored by Alizyme. Started Dec 2005; status: completed.
02
Drugs
renzapride
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on ISRCTN75871030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75871030.